NCT00186628 2017-11-28Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHDStanford UniversityPhase 2 Completed36 enrolled 12 charts
NCT00118352 2017-05-30Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed12 enrolled 10 charts